Supplementary Figure 3:
Influence of VE-821 on purine analog-induced cytotoxicity. Primary resting CLL cells were preincubated with or without 10 μM VE-821 before addition of F-Ara-A (A) or CdA (B) at increasing concentrations. Cell viability was measured after 96 h by the MTT assay. Results are means ± SEM of 14 separate experiments. Significance relative to the absence of VE-821: *P < 0.05; ***P < 0.001; ****P < 0.0001.
Supplementary Figure 2:
Influence of the ATR inhibitor VE-821 or ATR siRNA on the induction of p53 by purine analogs in the CLL cell line EHEB. EHEB cells were preincubated with 10 μM VE-821 (A) or transfected for 48 h with scramble or ATR siRNA (B) before addition of 30 μM fludarabine (F-Ara-A) or 10 μM cladribine (CdA). Activation of p53 (p53-pSer15 and p53 protein level) was analyzed after 24 h of incubation. Phosphorylation of Chk1 at Ser-317 was measured to verify ATR inhibition. β-actin was used as loading control. It should be noted that high doses of fludarabine or cladribine were used in these experiments due to relatively low sensitivity of EHEB cells to purine analogs. EHEB cells were transfected with ATR siRNA using the Amaxa™ nucleofector and nucleofection Kit V (Amaxa, Cologne, Germany) as previously reported [18] . CLL cells were preincubated in the presence or absence of 10 μM VE-821 before addition of labeled CdA (1 μM) or F-Ara-A (3 μM). F-Ara-ATP and CdATP, or their incorporation into nucleic acids were measured after 24 and/or 48 h of incubation as described previously [41] . Results are means ± SEM of 3 separate experiments. Significance relative to the absence of VE-821: * P < 0.05; ns: not significant. Concentrations of analog triphosphate in the absence of VE-821 were 33.1 ± 6.7 pmol/mg protein after 24 h of incubation with CdA, and 67.8 ± 5.2 and 71.3 ± 4.2 pmol/mg protein after 24 or 48 h of incubation with F-Ara-A. Incorporation into nucleic acids in the same conditions were 8.8 ± 1.5 pmol/mg protein after 24 h of incubation with CdA, and 1.2 ± 0.2 and 1.6 ± 0.4 pmol/mg protein after 24 or 48 h of incubation with F-Ara-A. 
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